Medyssey Co Ltd
200580
Company Profile
Business description
Medyssey Co Ltd designs, develops, manufactures and markets products for the surgical treatment of spine disorders. The main products of the company include spinal implants used in surgeries to treat spinal instability caused by spinal degeneration, stenosis, external trauma, or tumors, and spinal fusions for the treatment of congenital and acquired spinal deformities and scoliosis.
Contact
129, Hanbang Expo-ro
Wangam-dong
Chungcheongbuk-do
Jecheon-si27116
KORT: +82 437161014
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
93
Stocks News & Analysis
stocks
Goldman Sachs Earnings: Valuations remain stretched
We raise our fair value estimate for Goldman Sachs stock.
stocks
Major ASX listed miners overvalued
We’ve adjusted our fair values after updating our commodity price assumptions.
stocks
Undervalued ASX share with pathway to positive cash flow
Higher sales and a new loan facility increase our conviction.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,194.90 | 12.40 | -0.13% |
| CAC 40 | 8,092.05 | 166.89 | -2.02% |
| DAX 40 | 24,935.11 | 362.02 | -1.43% |
| Dow JONES (US) | 49,359.33 | 83.11 | -0.17% |
| FTSE 100 | 10,198.17 | 37.12 | -0.36% |
| HKSE | 26,563.90 | 281.06 | -1.05% |
| NASDAQ | 23,515.39 | 14.63 | -0.06% |
| Nikkei 225 | 53,583.57 | 352.60 | -0.65% |
| NZX 50 Index | 13,580.29 | 137.81 | -1.00% |
| S&P 500 | 6,940.01 | 4.46 | -0.06% |
| S&P/ASX 200 | 8,874.50 | 9.20 | -0.10% |
| SSE Composite Index | 4,114.00 | 12.09 | 0.29% |